ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $101,000 | +17.4% | 68,958 | +13.8% | 0.00% | – |
| Q4 2016 | $86,000 | -13.1% | 60,600 | +7.0% | 0.00% | – |
| Q3 2016 | $99,000 | +2.1% | 56,656 | +0.4% | 0.00% | – |
| Q2 2016 | $97,000 | +54.0% | 56,438 | +75.9% | 0.00% | – |
| Q1 2016 | $63,000 | -3.1% | 32,087 | -6.2% | 0.00% | – |
| Q4 2015 | $65,000 | +3.2% | 34,217 | +3.4% | 0.00% | – |
| Q3 2015 | $63,000 | -59.6% | 33,080 | -1.3% | 0.00% | – |
| Q2 2015 | $156,000 | -98.5% | 33,515 | -98.9% | 0.00% | -100.0% |
| Q4 2014 | $10,294,000 | -8.0% | 2,966,665 | +11.1% | 0.00% | 0.0% |
| Q3 2014 | $11,187,000 | +27.6% | 2,669,924 | +78.4% | 0.00% | +33.3% |
| Q2 2014 | $8,770,000 | -24.6% | 1,496,630 | -19.0% | 0.00% | -40.0% |
| Q1 2014 | $11,638,000 | +63.0% | 1,847,224 | +51.4% | 0.01% | +66.7% |
| Q4 2013 | $7,139,000 | +53.9% | 1,220,356 | +38.7% | 0.00% | +50.0% |
| Q3 2013 | $4,638,000 | – | 879,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |